Sub-NOAEL amounts of vinclozolin and xenoestrogens target rat chondrogenesis in vivo

Biochimie
Thuy-Anh AuxietreJean-François Savouret

Abstract

Several endocrine disrupting compounds (EDC) elicit skeletal dysgenesis at pharmacological doses. We have investigated the impact of doses below the "No Observed Adverse Effect" (NOAEL) for vinclozolin (V), an anti-androgenic fungicide, alone or associated with xenoestrogens (Genistein, G and bisphenol-A, BPA). V, G, BPA and their combinations were administered orally to female Wistar rats during gestation and lactation. F1 and F2 offspring were investigated for skeletal anomalies at post-natal days 30, 110 (d30, d110). Skeletal development was monitored by measuring caudal vertebrae and long bones dimensions by X-ray micro-CT-scan. A significant increase in Inter Transverse Apophysis (ITA) distance at the upper head of caudal vertebrae, associated with a reduction in vertebral body height was observed in treated F1 females, but not males. Histometrical analysis of vertebral body growth plate cartilage was performed on serial sections of caudal vertebrae. F1 females but not males showed a diminution in growth plate thickness, with greater impact on the hypertrophic zone. All effects were maximal at d30. Effects on ITA width persisted until d110 while effects on growth plate disappeared. These effects were essentially vinclozoli...Continue Reading

References

Sep 1, 1988·Journal of Steroid Biochemistry·N DayaniR Rappaport
Oct 20, 1994·The New England Journal of Medicine·E P SmithK S Korach
Jul 1, 1995·Research in Veterinary Science·H M BurbidgeH Hodge
Dec 1, 1995·The Journal of Clinical Endocrinology and Metabolism·A MorishimaK Qin
Oct 13, 2000·Regulatory Toxicology and Pharmacology : RTP·J HellwigC Gembardt
Jun 21, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·R W TylJ M Waechter
Oct 26, 2002·American Journal of Medical Genetics·Christine M Hall
Jul 5, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Thomas StrohekerMarie Christine Chagnon
Apr 19, 2005·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Elena MenegolaErminio Giavini
Jul 16, 2005·Food Additives and Contaminants·Jean-Charles LeblancPhilippe Verger
Sep 16, 2006·Endocrinology·Matthew D AnwayMichael K Skinner
Apr 17, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R Michael McClainJochen Bausch
Aug 7, 2007·Neurosurgery Clinics of North America·Mark S Dias
Sep 20, 2007·The Journal of Clinical Endocrinology and Metabolism·Andrei S Chagin, Lars Sävendahl
Jan 11, 2011·International Journal of Hygiene and Environmental Health·Nathalie ArnichJacques Tulliez
Sep 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Zhengui Zheng, Martin J Cohn
Nov 30, 2012·Surgical and Radiologic Anatomy : SRA·Michał SzpindaDariusz Króliczewski
Apr 3, 2013·Toxicology and Applied Pharmacology·Wenjuan TanLai K Leung

❮ Previous
Next ❯

Citations

Oct 2, 2019·Nutrients·Alexandre LeeCatherine Bennetau-Pelissero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved